MP-0317

N/A

Report date: 2025/06/26 20:00:07

Base Information

Drug NameMP-0317

Drug Alias NameMP-0317

ClassificationBiologics > Protein drugs

Mechanisms of ActionT lymphocytes stimulantsTumor necrosis factor receptor superfamily member 5 agonistsFibroblast activation protein alpha modulators

TargetsTumor necrosis factor receptor superfamily member 5Prolyl endopeptidase FAP

Therapy Area/IndicationsSolid tumoursBiliary Tract Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsFrance

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMolecular Partners Ag

China Registration ClassN/A

Develop Information

Active CompaniesMolecular Partners Ag

Inactive CompaniesN/A

Active IndicationsBiliary Tract Neoplasms

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A